Enveric Biosciences, Inc.

NasdaqCM:ENVB 株式レポート

時価総額:US$4.4m

Enveric Biosciences バランスシートの健全性

財務の健全性 基準チェック /46

Enveric Biosciences has a total shareholder equity of $5.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $6.1M and $645.3K respectively.

主要情報

0%

負債資本比率

US$0

負債

インタレスト・カバレッジ・レシオn/a
現金US$3.50m
エクイティUS$5.41m
負債合計US$645.34k
総資産US$6.05m

財務の健全性に関する最新情報

Recent updates

An Intrinsic Calculation For Enveric Biosciences, Inc. (NASDAQ:ENVB) Suggests It's 40% Undervalued

Jul 02
An Intrinsic Calculation For Enveric Biosciences, Inc. (NASDAQ:ENVB) Suggests It's 40% Undervalued

Enveric Biosciences to raise $8M in stock offering for corporate use

Jul 25

Enveric Biosciences Goes Psychedelic With MagicMed Acquisition

May 31

Enveric Biosciences announces $10M registered direct offering

Jan 12

財務状況分析

短期負債: ENVB's short term assets ($5.5M) exceed its short term liabilities ($645.3K).

長期負債: ENVB has no long term liabilities.


デット・ツー・エクイティの歴史と分析

負債レベル: ENVB is debt free.

負債の削減: ENVB currently has no debt however we can't compare to 5 years ago as we have no data for that period.


貸借対照表


キャッシュ・ランウェイ分析

過去に平均して赤字であった企業については、少なくとも1年間のキャッシュ・ランウェイがあるかどうかを評価する。

安定したキャッシュランウェイ: ENVB has less than a year of cash runway based on its current free cash flow.

キャッシュランウェイの予測: ENVB has less than a year of cash runway if free cash flow continues to reduce at historical rates of 35.9% each year


健全な企業の発掘